A61L 2300/416
Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents
Official title: Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
A61L2300/416 (Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents) appears on 1,515 US grants and 2,560 published applications in this corpus.
Search patents in A61L- Granted patents
- 1,515
- Published applications
- 2,560
- Assignees
- 723
- Inventors
- 2,904
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 6 | 0 |
| 1995 | 8 | 0 |
| 1996 | 9 | 0 |
| 1997 | 17 | 0 |
| 1998 | 28 | 0 |
| 1999 | 15 | 0 |
| 2000 | 17 | 0 |
| 2001 | 26 | 15 |
| 2002 | 40 | 72 |
| 2003 | 42 | 106 |
| 2004 | 29 | 112 |
| 2005 | 23 | 201 |
| 2006 | 34 | 131 |
| 2007 | 34 | 165 |
| 2008 | 27 | 126 |
| 2009 | 29 | 132 |
| 2010 | 59 | 132 |
| 2011 | 74 | 120 |
| 2012 | 90 | 121 |
| 2013 | 99 | 109 |
| 2014 | 106 | 112 |
| 2015 | 100 | 120 |
| 2016 | 84 | 131 |
| 2017 | 89 | 91 |
| 2018 | 64 | 83 |
| 2019 | 61 | 94 |
| 2020 | 54 | 80 |
| 2021 | 55 | 84 |
| 2022 | 40 | 40 |
| 2023 | 46 | 58 |
| 2024 | 52 | 58 |
| 2025 | 32 | 41 |
| 2026 | 16 | 26 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cationic nanodrug, preparation method therefor, and drug-loaded implantable medical device1 Sep 2026US 12,721,934 B2Shanghai Microport Medical (Group) Co., Ltd.
- Drug coated balloon1 Sep 2026US 12,721,977 B2Medtronic Vascular, Inc.
- Drug-eluting medical implants4 Aug 2026US 12,697,420 B2Lyra Therapeutics, Inc.
- Method for treatment of airway stricture or stenosis28 Jul 2026US 12,691,262 B2Airiver Medical, Inc.
- Polymeric biomaterials derived from phenolic monomers and their medical uses7 Jul 2026US 12,674,024 B2Rutgers, The State University of New Jersey
- Trodusquemine-coated balloon for targeted treatment of atherosclerosis8 Oct 2026US 2026/0306719 A1Bard Peripheral Vascular, Inc.
- Method for treatment of airway stricture or stenosis8 Oct 2026US 2026/0306805 A1Airiver Medical, Inc.
- Use of nanocrystals for drug delivery from a balloon10 Sep 2026US 2026/0263662 A1Boston Scientific Scimed, Inc.
- Porous Polymer Scaffolds, and Methods of Making and Using the Same27 Aug 2026US 2026/0250477 A1The Regents of the University of California
- Radiation spacer hydrogels, methods of forming, and methods of use20 Aug 2026US 2026/0241075 A1Clearstream Technologies Limited
Most cited
By later US patents
- Dilating and support apparatus with disease inhibitors and methods for use1,862US 6,450,989 B2Artemis Medical, Inc. · 2002
- Drug releasing anastomosis devices and methods for treating anastomotic sites1,779US 7,108,701 B2Ethicon, Inc. · 2006
- Sutures and surgical staples for anastamoses, wound closures, and surgical closures1,385US 8,016,881 B2ICON Interventional Systems, Inc. · 2011
- Extraction of solvents from drug containing polymer reservoirs1,360US 8,273,404 B2Cordis Corporation · 2012
- Vascular closure device1,319US 8,790,684 B2Cordis Corporation · 2014